Bhagiradha Chemicals and Industries Limited is an India-headquartered agrochemical manufacturer specialising in active ingredients, intermediates and formulations, operating an existing Andhra Pradesh plant (3,250 MT capacity) and a newly commissioned subsidiary plant in Karnataka (9,002 MT planned capacity), with an R&D-led product pipeline of 30+ molecules and strong customer relationships across 20+ countries.

The company is executing a transformational Rs.800+ crore multi-phase expansion through wholly owned Bheema Fine Chemicals to add 9,002 MTPA capacity, modern automated process lines, ZLD and a solar project, with Phase 1 commercial ramps already underway and Phase 2 targeted by H1FY28 to materially increase revenue potential and margins.

Financials show recovery: 9MFY26 consolidated revenue grew 19% to Rs.377.8 crore and EBITDA rose 22% to Rs.37.7 crore, while PAT dipped 4% to Rs.14.1 crore due to higher finance costs and depreciation, indicating operating improvement but near-term profitability pressure from elevated working capital and project-related costs.

Operational strengths include DSIR-approved R&D, eight synthesis labs with 60+ chemists, pilot and semi-commercial plants, and a deliberate backward integration strategy to move to N-7/N-9 process stages for key molecules, positioning Bhagiradha Chemicals and Industries Limited to capture higher gross margins and reduce import dependence.

Key risks remain elevated working capital days (192 days FY25), higher debtor and inventory days, execution and ramp-up timing of large capex, and reliance on shrinking export share; however, recent process improvements, product launches and a commissioned 4MW solar plant provide early signs of margin recovery and sustainability benefits.